Cryo-Cell International (FRA:ZCY) COGS-to-Revenue : 0.28 (As of Feb. 2024)

View and export this data going back to 1990. Start your Free Trial

What is Cryo-Cell International COGS-to-Revenue?

Cryo-Cell International's Cost of Goods Sold for the three months ended in Feb. 2024 was €2.00 Mil. Its Revenue for the three months ended in Feb. 2024 was €7.28 Mil.

Cryo-Cell International's COGS to Revenue for the three months ended in Feb. 2024 was 0.28.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Cryo-Cell International's Gross Margin % for the three months ended in Feb. 2024 was 72.48%.

Cryo-Cell International COGS-to-Revenue Historical Data

The historical data trend for Cryo-Cell International's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryo-Cell International COGS-to-Revenue Chart

Cryo-Cell International Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

COGS-to-Revenue

Get a 7-Day Free Trial

0.32

0.31

0.29

0.27

Cryo-Cell International Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
COGS-to-Revenue	Get a 7-Day Free Trial															0.26	0.28	0.27	0.26	0.28

Cryo-Cell International COGS-to-Revenue Calculation

Cryo-Cell International's COGS to Revenue for the fiscal year that ended in Nov. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	7.801	/	28.962
	=	0.27

Cryo-Cell International's COGS to Revenue for the quarter that ended in Feb. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	2.003	/	7.279
	=	0.28

Cryo-Cell International (FRA:ZCY) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Cryo-Cell International's Gross Margin % for the three months ended in Feb. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	2.003 / 7.279
	=	72.48 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Cryo-Cell International COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cryo-Cell International's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryo-Cell International (FRA:ZCY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cryo-Cell International Inc (FRA:ZCY) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

CCEL:USA

Address

700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677

Website

https://www.cryo-cell.com

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.

Cryo-Cell International (FRA:ZCY) Headlines

No Headlines